Prévisions du marché de la découverte d\'anticorps en Amérique du Nord jusqu\'en 2030 - Analyse régionale - par type d\'anticorps (anticorps monoclonaux, anticorps polyclonaux et autres), nature (humain et humanisé, chimérique et murin), services (phage display, hybridome, animal transgénique, cellule unique et affichage de levure) et utilisateur final (sociétés pharmaceutiques et biotechnologiques, laboratoires de recherche et autres)
L\'augmentation des investissements dans la recherche et le développement alimente le marché nord-américain de la découverte d\'anticorps
Les anticorps, y compris les anticorps monoclonaux et polyclonaux, trouvent des applications dans les instituts et organisations universitaires, de recherche et pharmaceutiques, où ils sont utilisés dans plusieurs activités de R&D liées au développement de médicaments et de biomarqueurs, et au développement d\'autres produits de diagnostic thérapeutique et clinique. Les petites et moyennes entreprises s\'efforcent d\'augmenter leurs investissements en R&D chaque année. En avril 2020, le gouvernement fédéral américain a alloué 3,5 milliards de dollars à la Biomedical Advanced Research and Development Authority (BARDA) dans le cadre de sa loi CARES (Coronavirus Aid, Relief, and Economic Security) afin de fournir un soutien financier à la fabrication, à la production et à l\'approvisionnement de vaccins, de diagnostics, de produits thérapeutiques et d\'ingrédients pharmaceutiques actifs (API) à petites molécules, entre autres. En outre, Bio-Rad, une société pharmaceutique, fournit 10 000 anticorps, ainsi que des antigènes, des réactifs et des tampons, pour développer des tests de diagnostic in vitro. Par conséquent, les investissements croissants des sociétés pharmaceutiques dans les activités de recherche et développement liées à la découverte d\'anticorps pour développer de meilleures options de traitement pour diverses maladies propulsent la croissance du marché de la découverte d\'anticorps.
Aperçu du marché de la découverte d\'anticorps en Amérique du Nord
Le marché nord-américain de la découverte d\'anticorps est segmenté entre les États-Unis, le Canada et le Mexique. La croissance du marché dans la région est déterminée par une augmentation de la prévalence du cancer, la forte présence de l\'industrie de la recherche sur les anticorps et les avancées technologiques dans le secteur de la R&D. Selon l\'American Cancer Society, environ 1,8 million de nouveaux cas de cancer ont été diagnostiqués et environ 606 520 décès liés au cancer ont été enregistrés aux États-Unis en 2020. Cela renforce le besoin d\'anticorps thérapeutiques, alimentant ainsi la croissance du marché de la découverte d\'anticorps. Une augmentation du financement permet en outre le développement de nouvelles technologies, la mise en commun des ressources et de l\'expertise entre les pays et les organisations, et la réalisation de travaux de recherche sur les traitements par anticorps existants. Cela a conduit à une meilleure compréhension du système immunitaire et au développement d\'anticorps efficaces et ciblés. De plus, l\'augmentation du financement permet aux scientifiques de mener des essais cliniques à grande échelle qui sont obligatoires pour évaluer l\'efficacité d\'un anticorps particulier.
Chiffre d\'affaires et prévisions du marché de la découverte d\'anticorps en Amérique du Nord jusqu\'en 2030 (milliards de dollars américains)
Segmentation du marché de la découverte d\'anticorps en Amérique du Nord
Le marché nord-américain de la découverte d\'anticorps est classé en type d\'anticorps, nature, services, utilisateur final et pays.
En fonction du type d\'anticorps, le marché nord-américain de la découverte d\'anticorps est segmenté en anticorps monoclonaux, anticorps polyclonaux et autres. Français Le segment des anticorps monoclonaux détenait la plus grande part de marché de la découverte d\'anticorps en Amérique du Nord en 2022.
En termes de nature, le marché de la découverte d\'anticorps en Amérique du Nord est segmenté en humain et humanisé, chimérique et murin. Le segment humain et humanisé détenait la plus grande part de marché de la découverte d\'anticorps en Amérique du Nord en 2022.
Par services, le marché nord-américain de la découverte d\'anticorps est divisé en affichage de phages, hybridome, animal transgénique, cellule unique et affichage de levure. Le segment de l\'affichage de phages détenait la plus grande part de marché de la découverte d\'anticorps en Amérique du Nord en 2022.
Sur la base de l\'utilisateur final, le marché nord-américain de la découverte d\'anticorps est classé en sociétés pharmaceutiques et biotechnologiques, laboratoires de recherche et autres. Le segment des sociétés pharmaceutiques et biotechnologiques détenait la plus grande part de marché de la découverte d\'anticorps en Amérique du Nord en 2022.
Sur la base du pays, le marché nord-américain de la découverte d\'anticorps est classé aux États-Unis, au Canada et au Mexique. Les États-Unis ont dominé la part de marché de la découverte d\'anticorps en Amérique du Nord en 2022.
Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Bruker Cellular Analysis Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, NanoCellect Biomedical Inc et Biocytogen Pharmaceuticals Beijing Co Ltd. sont quelques-unes des principales sociétés opérant sur le marché de la découverte d\'anticorps en Amérique du Nord.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Antibody Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Investments in Research & Development
4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
4.2.1 High Cost of Production
4.3 Market Opportunities
4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:
5. Antibody Discovery Market - North America Market Analysis
5.1 North America Antibody Discovery Market Revenue (US$ Million), 2020-2030
6. North America Antibody Discovery Market Analysis - by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Antibody Discovery Market Analysis - by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Antibody Discovery Market Analysis - by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Antibody Discovery Market Analysis - by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Antibody Discovery Market - Country Analysis
10.1 North America Market Overview
10.1.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
10.1.1.1 US
10.1.1.1.1 Overview
10.1.1.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 United States: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 United States: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 United States: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Canada
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Canada: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Canada: Antibody Discovery Market Breakdown, by End User
10.1.1.3 Mexico
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 Mexico: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Biolabs Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bruker Cellular Analysis Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BioDuro LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Sartorius AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Aragen Life Sciences Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Twist Bioscience Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NanoCellect Biomedical Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Biocytogen Pharmaceuticals Beijing Co Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. North America Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 16. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 17. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. North America Antibody Discovery Market Segmentation, by Country
Figure 2. North America Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. North America Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. US: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- Creative Biolabs Inc
- Evotec SE
- Bruker Cellular Analysis Inc
- BioDuro LLC
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- NanoCellect Biomedical Inc
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.